VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Jennifer Wu on Immunotherapy in Mismatch Repair Deficient CRC

Jennifer Wu, MD
Published: Friday, Dec 04, 2015



Jennifer Wu, MD, assistant professor of Medicine, Department of Medicine, Perlmutter Cancer Center, NYU Langone Medical Center, discusses the potential for immunotherapy in colorectal cancer with mismatch repair deficiency.

The mutational rate of colorectal cancer with mismatch repair deficiency is around 1,500, says Wu, while the mutational rate in non-deficient colorectal cancer is around 40. Immunotherapies seem to be most effective in cancers with high mutational loads.

A recent study published in the New England Journal of Medicine found that all patients with colorectal cancer with mismatch repair deficiency that received immunotherapy had a response. Progression-free survival has not yet been reached. While this study was small, the results are very exciting, says Wu.



Jennifer Wu, MD, assistant professor of Medicine, Department of Medicine, Perlmutter Cancer Center, NYU Langone Medical Center, discusses the potential for immunotherapy in colorectal cancer with mismatch repair deficiency.

The mutational rate of colorectal cancer with mismatch repair deficiency is around 1,500, says Wu, while the mutational rate in non-deficient colorectal cancer is around 40. Immunotherapies seem to be most effective in cancers with high mutational loads.

A recent study published in the New England Journal of Medicine found that all patients with colorectal cancer with mismatch repair deficiency that received immunotherapy had a response. Progression-free survival has not yet been reached. While this study was small, the results are very exciting, says Wu.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x